N-(1-methyl-2-oxo-3,4-dihydroquinolin-7-yl)-2-[8-(trifluoromethyl)-3,4-dihydro-2H-1-benzoxepin-5-ylidene]acetamide

C23H21F3N2O3 — CID 67039413

IUPACN-(1-methyl-2-oxo-3,4-dihydroquinolin-7-yl)-2-[8-(trifluoromethyl)-3,4-dihydro-2H-1-benzoxepin-5-ylidene]acetamide
SMILESCN1C(=O)CCc2ccc(NC(=O)C=C3CCCOc4cc(C(F)(F)F)ccc43)cc21
InChIInChI=1S/C23H21F3N2O3/c1-28-19-13-17(7-4-14(19)5-9-22(28)30)27-21(29)11-15-3-2-10-31-20-12-16(23(24,25)26)6-8-18(15)20/h4,6-8,11-13H,2-3,5,9-10H2,1H3,(H,27,29)
InChIKeyGEXHGELKPSWVCT-UHFFFAOYSA-N
MW430.43 g/mol
LogP4.81
Rot. Bonds2

About N-(1-methyl-2-oxo-3,4-dihydroquinolin-7-yl)-2-[8-(trifluoromethyl)-3,4-dihydro-2H-1-benzoxepin-5-ylidene]acetamide

N-(1-methyl-2-oxo-3,4-dihydroquinolin-7-yl)-2-[8-(trifluoromethyl)-3,4-dihydro-2H-1-benzoxepin-5-ylidene]acetamide (PubChem CID 67039413) has the molecular formula C23H21F3N2O3 and a molecular weight of 430.43 g/mol. Its IUPAC name is N-(1-methyl-2-oxo-3,4-dihydroquinolin-7-yl)-2-[8-(trifluoromethyl)-3,4-dihydro-2H-1-benzoxepin-5-ylidene]acetamide.

Molecular Properties

Compound NameN-(1-methyl-2-oxo-3,4-dihydroquinolin-7-yl)-2-[8-(trifluoromethyl)-3,4-dihydro-2H-1-benzoxepin-5-ylidene]acetamide
PubChem CID67039413
Molecular FormulaC23H21F3N2O3
Molecular Weight430.43 g/mol
Exact Mass430.15
IUPAC NameN-(1-methyl-2-oxo-3,4-dihydroquinolin-7-yl)-2-[8-(trifluoromethyl)-3,4-dihydro-2H-1-benzoxepin-5-ylidene]acetamide
SMILESCN1C(=O)CCc2ccc(NC(=O)C=C3CCCOc4cc(C(F)(F)F)ccc43)cc21
InChIInChI=1S/C23H21F3N2O3/c1-28-19-13-17(7-4-14(19)5-9-22(28)30)27-21(29)11-15-3-2-10-31-20-12-16(23(24,25)26)6-8-18(15)20/h4,6-8,11-13H,2-3,5,9-10H2,1H3,(H,27,29)
InChIKeyGEXHGELKPSWVCT-UHFFFAOYSA-N
XLogP4.81
TPSA58.64 Ų
H-Bond Donors1
H-Bond Acceptors3
Rotatable Bonds2
Heavy Atoms31
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500430.43
LogP ≤ 54.81
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 103

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze N-(1-methyl-2-oxo-3,4-dihydroquinolin-7-yl)-2-[8-(trifluoromethyl)-3,4-dihydro-2H-1-benzoxepin-5-ylidene]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-(1-methyl-2-oxo-3,4-dihydroquinolin-7-yl)-2-[8-(trifluoromethyl)-3,4-dihydro-2H-1-benzoxepin-5-ylidene]acetamide?
The IUPAC name of N-(1-methyl-2-oxo-3,4-dihydroquinolin-7-yl)-2-[8-(trifluoromethyl)-3,4-dihydro-2H-1-benzoxepin-5-ylidene]acetamide (CID 67039413) is N-(1-methyl-2-oxo-3,4-dihydroquinolin-7-yl)-2-[8-(trifluoromethyl)-3,4-dihydro-2H-1-benzoxepin-5-ylidene]acetamide.
What is the SMILES notation for N-(1-methyl-2-oxo-3,4-dihydroquinolin-7-yl)-2-[8-(trifluoromethyl)-3,4-dihydro-2H-1-benzoxepin-5-ylidene]acetamide?
The canonical SMILES for N-(1-methyl-2-oxo-3,4-dihydroquinolin-7-yl)-2-[8-(trifluoromethyl)-3,4-dihydro-2H-1-benzoxepin-5-ylidene]acetamide is CN1C(=O)CCc2ccc(NC(=O)C=C3CCCOc4cc(C(F)(F)F)ccc43)cc21.
What is the InChIKey of N-(1-methyl-2-oxo-3,4-dihydroquinolin-7-yl)-2-[8-(trifluoromethyl)-3,4-dihydro-2H-1-benzoxepin-5-ylidene]acetamide?
The InChIKey is GEXHGELKPSWVCT-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H21F3N2O3/c1-28-19-13-17(7-4-14(19)5-9-22(28)30)27-21(29)11-15-3-2-10-31-20-12-16(23(24,25)26)6-8-18(15)20/h4,6-8,11-13H,2-3,5,9-10H2,1H3,(H,27,29).
What are the key properties of N-(1-methyl-2-oxo-3,4-dihydroquinolin-7-yl)-2-[8-(trifluoromethyl)-3,4-dihydro-2H-1-benzoxepin-5-ylidene]acetamide?
N-(1-methyl-2-oxo-3,4-dihydroquinolin-7-yl)-2-[8-(trifluoromethyl)-3,4-dihydro-2H-1-benzoxepin-5-ylidene]acetamide has a molecular weight of 430.43 g/mol, XLogP of 4.81, 2 rotatable bonds, 1 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for N-(1-methyl-2-oxo-3,4-dihydroquinolin-7-yl)-2-[8-(trifluoromethyl)-3,4-dihydro-2H-1-benzoxepin-5-ylidene]acetamide is sourced from PubChem (CID 67039413), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).